Skip to main content

Table 4 48-hour pH parameters through the phases of the study in patients initially randomized to the high-dose proton-pump inhibitors (PPIs) group (A) and to the transoral fundoplication (TF) group (B)

From: Efficacy of transoral fundoplication for treatment of chronic gastroesophageal reflux disease incompletely controlled with high-dose proton-pump inhibitors therapy: a randomized, multicenter, open label, crossover study

A Parameters

Screening (off PPIs)

6-month on high-dose PPIs

6-month after TF (off PPIs)

p value (6-month PPIs vs. screening)

p value (6-month after TF vs. screening)

p value (PPIs vs.TF)

Number of refluxes

190.43 (89.36)

91.33 (68.01)

120.52 (64.25)

< 0.001

0.010

0.420

Number of long refluxes (>5 minutes)

12.52 (7.22)

4.62 (5.07)

10.00 (6.02)

< 0.001

0.387

0.017

Duration of longest reflux, minutes

26.48 (14.29)

23.76 (21.77)

24.86 (14.71)

0.867

0.950

0.977

Fraction time pH <4, %

10.50 (3.51)

5.01 (4.55)

7.87 (4.20)

< 0.001

0.070

0.104

DeMeester score

35.79 (13.05)

19.29 (16.07)

28.60 (14.71)

0.002

0.258

0.108

B Parameters

Screening (off PPIs)

6-month (off PPIs)

12-month (off PPIs)

p value (6-month vs. screening)

p value (12-month vs. screening)

p value (6-month vs. 12-month)

Number of refluxes

160.72 (76.71)

100.80 (83.58)

115.26 (61.28)

0.002

0.023

0.672

Number of long refluxes (>5 minutes)

12.62 (5.48)

8.54 (7.68)

10.24 (7.89)

0.030

0.297

0.536

Duration of longest reflux, minutes

31.36 (14.15)

23.41 (20.75)

23.82 (15.04)

0.010

0.128

0.994

Fraction time pH <4, %

10.19 (3.55)

6.77 (5.41)

7.45 (4.86)

0.005

0.031

0.800

DeMeester score

35.28 (11.80)

23.64 (18.54)

25.32 (15.50)

0.004

0.016

0.883

  1. Values represent means (standard deviation). PPI, proton pump inhibitor; TF, transoral fundoplication.